Percheron Therapeutics is an Australian publicly-listed biotechnology company, developing and commercializing antisense pharmaceuticals for large unmet markets in rare diseases. The products are in-licensed from Ionis Pharmaceuticals Inc. (NASDAQ: IONS), an established leader in antisense drug development.
Our commitment is to provide shareholders, potential investors, and the public with a transparent view of our efforts toward fulfilling our purpose: Breakthroughs that change patients’ lives. To that end, our annual reports detail the strategic development, operations, and financial condition of our business.
Percheron Therapeutics vision and mission is to bring life changing innovative medicines to patients in need and to add value for all stakeholders through actively exercising our beliefs of honesty, integrity and collaboration.
We serve the needs of our patients and stakeholders to the best of our combined abilities.
